The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

SUMMARY: Oral glucocorticoids may increase major osteoporotic fracture risk (MOF) in myasthenia gravis patients. To assess this risk, we performed a case–control study including all Danish patients with a MOF between 1995 and 2011. We also pooled our data with data from another study. We found no in...

Descripción completa

Detalles Bibliográficos
Autores principales: Safipour, Zohreh, van der Zanden, Rogier, van den Bergh, Joop, Janssen, Paddy, Vestergaard, Peter, de Vries, Frank, Driessen, Johanna H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843904/
https://www.ncbi.nlm.nih.gov/pubmed/34601629
http://dx.doi.org/10.1007/s00198-021-06101-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843904/
https://www.ncbi.nlm.nih.gov/pubmed/34601629
http://dx.doi.org/10.1007/s00198-021-06101-3

Ejemplares similares